ASH 2021: Dr. Constantine Tam on BTK Inhibitor TG-1701 for Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
At the American Society of Hematology (ASH) 2021, Dr. Alan Skarbnick, Director of the CLL program at Novant Health Cancer Institute in Charlotte, NC, interviewed Dr. Constantine Tam, a hematologist at the Peter McCallum Cancer Center in Melbourne, Australia. They discussed the results of a phase 1 clinical trial testing the combination of three different drugs: